Global Microbiome Skincare Products Market
Global Microbiome Skincare Products Market Projected to Surpass USD 1.32 Billion by 2034
March 27, 2024 08:59 ET | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Microbiome Skincare Products Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
Global Biopharmaceuticals Manufacturing Consumables Testing Market
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Forecast 2024-2030
March 15, 2024 05:39 ET | Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Global Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing,...
Rentschler Winner
Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
March 13, 2024 09:30 ET | Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
PaxMedica logo.jpg
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
March 13, 2024 08:20 ET | PaxMedica, Inc.
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
Global Regenerative Medicine Market
Regenerative Medicine Industry Analysis and Outlook 2024-2034: Oncology Applications Lead the Forecasted $168 Billion Global Market
March 11, 2024 13:40 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region" report has...
Global US Healthcare Advertising Market
US Healthcare Advertising Market Analysis Report 2024-2032: Increasing Presence of Generic and Me-too Drugs, Increased Consumer Reach through Mobile Advertising, Strict Rules and Regulations by FDA
March 08, 2024 06:35 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC)...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
March 06, 2024 04:00 ET | Rentschler Biopharma SE
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024 17:48 ET | MacroGenics, Inc.
ROCKVILLE, MD, March 01, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Bioprocess Validation Market
Bioprocess Validation Global Strategic Business Report 2024: Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
March 01, 2024 06:48 ET | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bioprocess Validation...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024 17:45 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...